Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding

被引:49
作者
Blaizot, MG
Biron-Andreani, C
Aguilar-Martinez, P
de Moeloose, P
Briquel, ME
Goudemand, J
Stieltjes, N
Barrot, C
Chambost, H
Durin, A
Gay, V
Peynet, J
Pouymayou, K
Schved, JF
机构
[1] Univ Hosp, Hematol Lab, Montpellier, France
[2] Univ Hosp, Hematol Lab, Geneva, Switzerland
[3] Univ Hosp, Haematol Lab, Nancy, France
[4] Univ Hosp, Dept Haematol, Lille, France
[5] Hosp Cochin, Haemophilia Ctr, Paris, France
[6] Univ Hosp, Haematol Lab, Grenoble, France
[7] Univ Hosp, Haematol Lab, Marseille, France
[8] Univ Hosp, Dept Pediat, Lyon, France
[9] Univ Hosp, Dept Haematol, Chambery, France
[10] Hemophilia Ctr, Le Chesnay, France
关键词
FVII deficiency; surgery; replacement therapy; haemorrhage; congenital haemorrhagic disorder;
D O I
10.1046/j.1365-2141.2002.03408.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inherited factor VII (FVII) deficiency is a rare autosomal disorder characterized by a weak relationship between FVII activity (FVII:C) and operative bleeding risk. We report a retrospective study of 17 patients with a FVII:C below 0.1 IU/ml, in whom surgery was performed without any replacement therapy. Clinical and biological data were analysed to establish predictive criteria for bleeding tendency. We found that systematic preoperative replacement therapy may not be necessary for 'minor' surgical procedures, for patients suffering from inherited FVII deficiency, unless the clinical history includes severe haemorrhagic symptoms such as haemarthrosis, severe haematomas (even of soft tissue) or abundant epistaxis.
引用
收藏
页码:172 / 175
页数:4
相关论文
共 12 条
[1]  
Cooper DN, 1997, THROMB HAEMOSTASIS, V78, P151
[2]  
de Moerloose P, 1998, BRIT J HAEMATOL, V100, P40
[3]   Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency [J].
Giansily-Blaizot, M ;
Aguilar-Martinez, P ;
Biron-Andreani, C ;
Janjean, P ;
Igual, H ;
Schved, JF .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (02) :105-112
[4]   ASSESSMENT OF MENSTRUAL BLOOD-LOSS USING A PICTORIAL CHART [J].
HIGHAM, JM ;
OBRIEN, PMS ;
SHAW, RW .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (08) :734-739
[5]   Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease [J].
Lak, M ;
Peyvandi, F ;
Mannucci, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1236-1239
[6]  
LAWSON JH, 1994, J BIOL CHEM, V269, P23357
[7]  
MARIANI G, 1983, HAEMOSTASIS, V13, P169
[8]   Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies [J].
Mariani, G ;
Testa, MG ;
Di Paolantonio, T ;
Bech, RM ;
Hedner, U .
VOX SANGUINIS, 1999, 77 (03) :131-136
[9]   Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency [J].
Peyvandi, F ;
Mannucci, PM ;
Asti, D ;
Abdoullahi, M ;
DiRocco, N ;
Sharifian, R .
HAEMOPHILIA, 1997, 3 (04) :242-246
[10]  
TRIPLETT DA, 1985, BLOOD, V66, P1284